Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction
There is limited information on the comparative results of using different thrombolytic drugs for pharmacoinvasive reperfusion in acute ST-segment elevation myocardial infarction (STEMI). There is special interest in comparing the efficacy of fibrin-selective and fibrin-non-selective thrombolytics.A...
Saved in:
| Main Authors: | A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2019-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1911 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IN-PATIENT OUTCOMES OF PHARMACOINVASIVE REPERFUSION STRATEGY FOR ST ELEVATION MYOCARDIAL INFARCTION
by: A. V. Khripun, et al.
Published: (2016-03-01) -
CORONARY REPERFUSION IN ST ELEVATION MYOCARDIAL INFARCTION: PROBLEMS AND SOLUTIONS
by: V. A. Markov, et al.
Published: (2015-01-01) -
Prospects for a pharmacoinvasive strategy in ST-elevation myocardial infarction in the Russian Federation
by: V. E. Oleynikov, et al.
Published: (2025-04-01) -
Pharmacoinvasive strategy in the treatment of acute myocardial infarction: current state-of-the-art
by: A. S. Tereshchenko, et al.
Published: (2021-07-01) -
PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON
by: E. V. Vyshlov, et al.
Published: (2015-02-01)